Latest From ResMed Inc.
Sleep apnea treatment company ResMed Corp. will pay $39.5m to settle allegations that it violated the False Claims Act by giving free or discounted goods and services to distributors and health-care providers to encourage the use of the firm’s devices.
For health-care providers and medtech manufacturers alike, the decade ahead will require a coming to terms with digital technologies and integrating new methods of payment. Quality of service delivery remains the market-entry criterion, but companies will have to adapt to evolving health-care models. The stakes are high. Will manufacturers be able to capitalize on the changes in a market that is more competitive and unpredictable than ever?
The winners of this year’s Medtech Insight Awards were revealed last night at a glittery ceremony in Boston. The awards, held in partnership with the MedTech Conference, recognized excellence and achievement across the industry.
San Diego, CA-based software-as-a-service company Seqster developed a technology that integrates data from electronic health records, genomics and wearables into one platform. Seqster's CEO Ardy Arianpour believes he has solved a major interoperability problem and hopes to attract providers, payers and pharma companies as clients.
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
- Therapeutic Areas
- Neurology, Nervous System
- Respiratory, Pulmonary
- North America
- Parent & Subsidiaries
- ResMed Inc.
- Senior Management
Michael Farrell, CEO
Robert Douglas, Pres. & COO
- Contact Info
Phone: (858) 836-5000
9001 Spectrum Ctr. Blvd.
San Diego, CA 92123
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.